Pfizer May 5, 2026 Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager - Fierce Biotech
Pfizer May 5, 2026 FDA approves Pfizer and Arvina’s breast cancer drug despite weak clinical data - medwatch.com
Pfizer May 4, 2026 Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - Yahoo Finance
Pfizer May 1, 2026 FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype - Fierce Pharma
Pfizer Apr 29, 2026 Pfizer looks to jump start Elrexfio with topline win in second-line myeloma - Fierce Pharma
Pfizer Apr 28, 2026 Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts - Fierce Pharma
Pfizer Apr 28, 2026 BofA raises BridgeBio Pharma stock price target on Pfizer settlement clarity - Investing.com
Pfizer Apr 28, 2026 Pfizer deals extend patent life for a top-selling rare disease drug - BioPharma Dive
FierceBiotech Apr 21, 2026 Pfizer's strategy head Andrew Baum to step down following brief tenure: reports